Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Michael G Douvas"'
Autor:
Aimee C Talleur, Brandon M Triplett, Haneen Shalabi, Bonnie Yates, Nirali N Shah, George Mo, Hao-Wei Wang, Shilpa A Shahani, Michael G Douvas, Katherine R Calvo, Jack F Shern, Sridhar Chaganti, Katharine Patrick, Young Song, Terry J Fry, Xiaolin Wu, Javed Khan, Rebecca A Gardner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Immunotherapeutic strategies targeting B-cell acute lymphoblastic leukemia (B-ALL) effectively induce remission; however, disease recurrence remains a challenge. Due to the potential for antigen loss, antigen diminution, lineage switch or development
Externí odkaz:
https://doaj.org/article/9165dfbe9bda40b7991cff5cb81c8857
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
Atypical chronic myeloid leukemia (aCML) is a rare myeloproliferative disorder that shares clinical features with chronic myeloid leukemia but lacks the classic t(9;22) BCR-ABL1 translocation and features prominent dysgranulopoiesis and granulocytic
Externí odkaz:
https://doaj.org/article/a6dc78fbcd8a42a381f6a0a1b7af2a33
Autor:
Christopher Y. Thomas, Snjezana Zaja-Milatovic, Nikole Varhegyi, Michael G. Douvas, Paula M. Fracasso, Christopher A. Moskaluk, Bethany J. Horton, Gina R. Petroni, Patrick M. Dillon
Purpose: Genetic and preclinical studies have implicated FGFR signaling in the pathogenesis of adenoid cystic carcinoma (ACC). Dovitinib, a suppressor of FGFR activity, may be active in ACC.Experimental Design: In a two-stage phase II study, 35 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5f9174364d8e9885de3a152a92f9e6
https://doi.org/10.1158/1078-0432.c.6526778
https://doi.org/10.1158/1078-0432.c.6526778
Autor:
Christopher Y. Thomas, Snjezana Zaja-Milatovic, Nikole Varhegyi, Michael G. Douvas, Paula M. Fracasso, Christopher A. Moskaluk, Bethany J. Horton, Gina R. Petroni, Patrick M. Dillon
Methodology and results for exploratory aims, FISH, IHC and quality of life. SUPPLEMENTAL FIGURE 1: Change point analysis including a second inflection point in calculation of average slope of 34 evaluable patients. Supplemental Figure 2: First, last
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1956e40fa9d3d7ff60ba7e76520560d1
https://doi.org/10.1158/1078-0432.22467902.v1
https://doi.org/10.1158/1078-0432.22467902.v1
Autor:
Michael G. Douvas, Lara L. Riegler
Publikováno v:
Current Hematologic Malignancy Reports. 17:15-24
To discuss the long-term view of treating and following pediatric, adolescent, and young adult patients with acute lymphoblastic leukemia (ALL) — with review of what can be done to prevent, monitor for, and treat complications of therapy. Pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88788b6afa01c3bd15a0bc1f7e3014d2
https://doi.org/10.1007/s11899-021-00657-x
https://doi.org/10.1007/s11899-021-00657-x
Autor:
Katharine Patrick, Xiaolin Wu, George Mo, Hao-Wei Wang, Haneen Shalabi, Shilpa A Shahani, Young Min Song, Katherine R. Calvo, Rebecca Gardner, Javed Khan, Terry J. Fry, Aimee C Talleur, Sridhar Chaganti, Nirali N. Shah, Michael G. Douvas, Jack F. Shern, Brandon M. Triplett, Bonnie Yates
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Immunotherapeutic strategies targeting B-cell acute lymphoblastic leukemia (B-ALL) effectively induce remission; however, disease recurrence remains a challenge. Due to the potential for antigen loss, antigen diminution, lineage switch or development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f75c0020931f6094e8a9f390fec6e53
https://pubmed.ncbi.nlm.nih.gov/33246985
https://pubmed.ncbi.nlm.nih.gov/33246985
Autor:
Paul W. Read, John B. Cousar, Michael G. Douvas, James F. Reibel, Asal N. Shoushtari, Randell L. Woodford, Neal E. Dunlap
Publikováno v:
Rare Tumors, Vol 2, Iss 1, Pp e9-e9 (2010)
We report the case of a primary nasopharyngeal interdigitating dendritic cell tumor (IDDCT). A 25-year old male presented with bilateral decreased hearing, double vision, and ataxia. Flexible nasopharyngoscopy reviewed a large mass obstructing and fi
Externí odkaz:
https://doaj.org/article/287586ba69444c75a947bac4923128aa
Autor:
Christopher A. Moskaluk, Patrick M. Dillon, Nikole Varhegyi, Michael G. Douvas, Snjezana Zaja-Milatovic, Bethany J. Horton, Gina R. Petroni, Paula M. Fracasso, Christopher Y. Thomas
Publikováno v:
Clinical Cancer Research. 23:4138-4145
Purpose: Genetic and preclinical studies have implicated FGFR signaling in the pathogenesis of adenoid cystic carcinoma (ACC). Dovitinib, a suppressor of FGFR activity, may be active in ACC. Experimental Design: In a two-stage phase II study, 35 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0ffb8b013f7a7cb001eeeb92a6098e
https://doi.org/10.1158/1078-0432.ccr-16-2942
https://doi.org/10.1158/1078-0432.ccr-16-2942
Publikováno v:
Annals of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e602699ba9c0c8ba631ea03767f10589
https://doi.org/10.1007/s00277-017-2930-0
https://doi.org/10.1007/s00277-017-2930-0
Publikováno v:
Current hematologic malignancy reports. 13(2)
Adolescent and Young Adult (AYA) Oncology is a relatively new field encompassing research in the unique pathophysiology, clinical care, and psychosocial issues facing patients between the ages of 15 and 40 with cancer. About 100,000 of the approximat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab18eba6cf67ee549192bb34110f79f
https://pubmed.ncbi.nlm.nih.gov/29442287
https://pubmed.ncbi.nlm.nih.gov/29442287